298 related articles for article (PubMed ID: 18975078)
1. Correlation of serum-soluble triggering receptor expressed on myeloid cells-1 with clinical disease activity in inflammatory bowel disease.
Park JJ; Cheon JH; Kim BY; Kim DH; Kim ES; Kim TI; Lee KR; Kim WH
Dig Dis Sci; 2009 Jul; 54(7):1525-31. PubMed ID: 18975078
[TBL] [Abstract][Full Text] [Related]
2. Correlation between soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) expression and endoscopic activity in inflammatory bowel diseases.
Jung YS; Park JJ; Kim SW; Hong SP; Kim TI; Kim WH; Cheon JH
Dig Liver Dis; 2012 Nov; 44(11):897-903. PubMed ID: 22721842
[TBL] [Abstract][Full Text] [Related]
3. Elevated levels of serum-soluble triggering receptor expressed on myeloid cells-1 in patients with IBD do not correlate with intestinal TREM-1 mRNA expression and endoscopic disease activity.
Saurer L; Rihs S; Birrer M; Saxer-Seculic N; Radsak M; Mueller C;
J Crohns Colitis; 2012 Oct; 6(9):913-23. PubMed ID: 22410349
[TBL] [Abstract][Full Text] [Related]
4. Expression of a soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) correlates with clinical disease activity in intestinal Behcet's disease.
Jung YS; Kim SW; Yoon JY; Lee JH; Jeon SM; Hong SP; Kim TI; Kim WH; Cheon JH
Inflamm Bowel Dis; 2011 Oct; 17(10):2130-7. PubMed ID: 21910175
[TBL] [Abstract][Full Text] [Related]
5. Levels of plasma-soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) are correlated with disease activity in rheumatoid arthritis.
Choi ST; Kang EJ; Ha YJ; Song JS
J Rheumatol; 2012 May; 39(5):933-8. PubMed ID: 22422501
[TBL] [Abstract][Full Text] [Related]
6. Plasma soluble triggering receptor expressed on myeloid cells-1 in Crohn's disease.
Billioud V; Gibot S; Massin F; Oussalah A; Chevaux JB; Williet N; Bronowicki JP; Bigard MA; Guéant JL; Peyrin-Biroulet L
Dig Liver Dis; 2012 Jun; 44(6):466-70. PubMed ID: 22341488
[TBL] [Abstract][Full Text] [Related]
7. Role of soluble triggering receptor expressed on myeloid cells in inflammatory bowel disease.
Tzivras M; Koussoulas V; Giamarellos-Bourboulis EJ; Tzivras D; Tsaganos T; Koutoukas P; Giamarellou H; Archimandritis A
World J Gastroenterol; 2006 Jun; 12(21):3416-9. PubMed ID: 16733861
[TBL] [Abstract][Full Text] [Related]
8. Correlation between soluble triggering receptor expressed on myeloid cells-1 and endoscopic activity in intestinal Behçet's disease.
Lee HJ; Shin HS; Jang HW; Kim SW; Park SJ; Hong SP; Kim TI; Kim WH; Cheon JH
Yonsei Med J; 2014 Jul; 55(4):960-6. PubMed ID: 24954324
[TBL] [Abstract][Full Text] [Related]
9. Increased levels of soluble triggering receptor expressed on myeloid cells-1 in patients with acute pancreatitis.
Yasuda T; Takeyama Y; Ueda T; Shinzeki M; Sawa H; Takahiro N; Kamei K; Ku Y; Kuroda Y; Ohyanagi H
Crit Care Med; 2008 Jul; 36(7):2048-53. PubMed ID: 18552693
[TBL] [Abstract][Full Text] [Related]
10. Total soluble and endogenous secretory receptor for advanced glycation endproducts (RAGE) in IBD.
Meijer B; Hoskin T; Ashcroft A; Burgess L; Keenan JI; Falvey J; Gearry RB; Day AS
J Crohns Colitis; 2014 Jun; 8(6):513-20. PubMed ID: 24291021
[TBL] [Abstract][Full Text] [Related]
11. Clinical Association of a Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) in Patients with Systemic Lupus Erythematosus.
Bassyouni IH; Fawzi S; Gheita TA; Bassyouni RH; Nasr AS; El Bakry SA; Afifi N
Immunol Invest; 2017 Jan; 46(1):38-47. PubMed ID: 27648678
[TBL] [Abstract][Full Text] [Related]
12. Dynamic changes of serum soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) reflect sepsis severity and can predict prognosis: a prospective study.
Zhang J; She D; Feng D; Jia Y; Xie L
BMC Infect Dis; 2011 Mar; 11():53. PubMed ID: 21356122
[TBL] [Abstract][Full Text] [Related]
13. Serum Interleukin-33 level in Saudi children with inflammatory bowel disease.
Saadah OI; Al-Harthi SE; Al-Mughales JA; Bin-Taleb YY; Baeshen RS
Int J Clin Exp Pathol; 2015; 8(12):16000-6. PubMed ID: 26884875
[TBL] [Abstract][Full Text] [Related]
14. Soluble triggering receptor expressed on myeloid cell-1 (sTREM-1): a new mediator involved in early ankylosing spondylitis.
Chen CH; Liao HT; Chen HA; Liang TH; Wang CT; Chou CT
J Rheumatol; 2008 Sep; 35(9):1846-8. PubMed ID: 18634145
[TBL] [Abstract][Full Text] [Related]
15. Soluble triggering receptor expressed on myeloid cells 1 and the diagnosis of sepsis.
Barati M; Bashar FR; Shahrami R; Zadeh MH; Taher MT; Nojomi M
J Crit Care; 2010 Jun; 25(2):362.e1-6. PubMed ID: 19914031
[TBL] [Abstract][Full Text] [Related]
16. Correlation between triggering receptor expressed on myeloid cells-1 and clinical disease activity in Chinese patients with ulcerative colitis.
Zhang S; Luo J; Shen B; Li L; Hu C; Li P; Deng C; Zhang F; Qian J; Li Y
Int J Clin Exp Med; 2015; 8(2):2147-55. PubMed ID: 25932145
[TBL] [Abstract][Full Text] [Related]
17. Circulating soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) as diagnostic and prognostic marker in neonatal sepsis.
Adly AA; Ismail EA; Andrawes NG; El-Saadany MA
Cytokine; 2014 Feb; 65(2):184-91. PubMed ID: 24290866
[TBL] [Abstract][Full Text] [Related]
18. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
[TBL] [Abstract][Full Text] [Related]
19. Measurement of plasma sTREM-1 in patients with severe sepsis receiving early goal-directed therapy and evaluation of its usefulness.
Jeong SJ; Song YG; Kim CO; Kim HW; Ku NS; Han SH; Choi JY; Kim JM
Shock; 2012 Jun; 37(6):574-8. PubMed ID: 22395243
[TBL] [Abstract][Full Text] [Related]
20. TWEAK is not elevated in patients with newly diagnosed inflammatory bowel disease.
Grimstad T; Skoie IM; Doerner J; Isaksen K; Karlsen L; Aabakken L; Omdal R; Putterman C
Scand J Gastroenterol; 2017 Apr; 52(4):420-424. PubMed ID: 28040992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
